Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of de-identified patient records across datasets.
Datavant’s partners use the company’s privacy protecting linking technology to connect together disparate data collected from patients. Datavant’s technology allows its partners to link the patient datasets together to build a longitudinal history without knowing the identity of those patients. Datavant provides the technology infrastructure for an open data ecosystem where partners retain full control of their data.
Datavant announced $40 million in Series B funding in October 2020, bringing Datavant’s cumulative fundraising to $83 million. The round was led by Transformation Capital, with participation by new investors Johnson & Johnson Innovation – JJDC, and Cigna Ventures, as well as participation by existing shareholders Roivant Sciences and Flex Capital. This investment is planned to support Datavant as it continues to expand the open healthcare data ecosystem.
Datavant’s recent partnerships with specialty hub providers include:
- IntegriChain recently announced a preferred partnership with Datavant to utilize the company’s patient de-identification and tokenization solutions to improve the patient-level integration of specialty pharmacy, hub, nurse, co-pay program, lab, and claims data sets.
- PRECISIONxtract and Datavant announced a market-shifting partnership where Precision will leverage the power of Datavant’s technology to support life science partners to better visualize and navigate the patient journey. This partnership will enable clients to deepen their visibility into the patient experience and solve key commercialization challenges that new therapies face.
- Datavant and EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, announced a strategic partnership in which EVERSANA will use Datavant’s data linking technology to enhance its advanced analytics capabilities. This partnership will power even deeper analytics through EVERSANA’s fully integrated commercial services platform, helping to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector.
Takeaway: Specialty hub providers are using Datavant technology to link disparate patient data sets preserving privacy